AMERITOX
A leader in pain medication monitoring and research.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 4 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination 3rd Quarter 2017
|
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | $40,000 reported |
|
2nd Quarter - Amendment 2nd Quarter 2017
|
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | $40,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2017
|
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | $40,000 reported |
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2017
|
POLSINELLI PC | — reported |
|
1st Quarter - Report 1st Quarter 2017
|
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | $40,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2017
|
POLSINELLI PC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| SQUIRE PATTON BOGGS | 19 | $1,880,000 |
| AKIN GUMP STRAUSS HAUER & FELD | 5 | $440,000 |
| BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) | 10 | $380,000 |
| POLSINELLI PC | 9 | $60,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medicare/Medicaid | MMM | 32 |
| Health Issues | HCR | 11 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.